These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7036711)

  • 21. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA microarray SNP associations with clinical efficacy and side effects of domperidone treatment for gastroparesis.
    Wang D; Parkman HP; Jacobs MR; Mishra AK; Krynetskiy E; Obradovic Z
    J Biomed Inform; 2012 Apr; 45(2):316-22. PubMed ID: 22179054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of domperidone maleate on chronic dyspepsia and gastric emptying].
    Marzio L; Di Giammarco AM; Capone F; Neri M; Mezzetti A; Cuccurullo F
    Minerva Dietol Gastroenterol; 1985; 31(4):591-5. PubMed ID: 3911108
    [No Abstract]   [Full Text] [Related]  

  • 25. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Nov; 24(5):360-400. PubMed ID: 6756878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
    Carpentier PH; Mathieu M
    J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.
    Schoffer KL; Henderson RD; O'Maley K; O'Sullivan JD
    Mov Disord; 2007 Aug; 22(11):1543-9. PubMed ID: 17557339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroparesis and the current use of prokinetic drugs.
    Kendall BJ; McCallum RW
    Gastroenterologist; 1993 Jun; 1(2):107-14. PubMed ID: 8049884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Domperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbances.
    Scarzella L; Costanza A; Vastola K
    Funct Neurol; 2007; 22(2):101-4. PubMed ID: 17637213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs in Focus: Domperidone.
    Puoti MG; Assa A; Benninga M; Broekaert IJ; Carpi FJM; Deganello Saccomani M; Dolinsek J; Homan M; Mas E; Miele E; Tzivinikos C; Thomson M; Borrelli O
    J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):e13-e22. PubMed ID: 37159421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial on the effect of domperidone on non-ulcer dyspepsia.
    Sarin SK; Sharma P; Chawla YK; Gopinath P; Nundy S
    Indian J Med Res; 1986 Jun; 83():623-8. PubMed ID: 3530997
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Jul; 26(1):107-16. PubMed ID: 17555427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical tolerability profile of alendronate.
    Watts N; Freedholm D; Daifotis A
    Int J Clin Pract Suppl; 1999 Apr; 101():51-61. PubMed ID: 12669741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.